The Vibes Are Off In The Treasurys Market By Hardika Singh Inflation and deficits are lifting government bond yields and jarring the stock market. Meanwhile, fundamentals suggest inflation.
By Chris Wack Poseida Therapeutics shares were up 18% to $2.86 after the company said it entered into a research collaboration and license agreement with Astellas Pharma s Xyphos Biosciences.
Poseida Therapeutics Shares Rise 18% After Licensing Deal With Xyphos Biosciences morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.
By Chris Wack MannKind said the Food and Drug Administration has cleared its Investigational New Drug application for MNKD-101 Clofazimine inhalation suspension, enabling the initiation of a.
By Chris Wack Prime Medicine said that the U.S. Food and Drug Administration has cleared its Investigational New Drug application for PM359 for the treatment of chronic granulomatous disease..